Healius (HLS) Stock Overview

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

HLS Stock Information

Symbol

HLS

Address

Liberty PlaceSydney, NSW 2000Australia

Founded

Trading hours

10:00 AM - 4:00 PM AEST

Website

https://www.healius.com.au

Country

🇦🇺 Australia

Phone Number

61 2 9432 9400

Healius (HLS) Price Chart

Healius Overview: Key Details and Summary

Stock data	2023	Change
Price	$1.13	N/A
Market Cap	$695.53M	N/A
Shares Outstanding	615.61M	-2.35%
Employees	10.50K	N/A
Shareholder Equity	1.51B	-21.62%

Valuation	2023	Change
P/E Ratio	-1.89	N/A
P/S Ratio	0.60	N/A
P/B Ratio	0.46	N/A

Growth	2023	Change
Return on Equity	-0.1652	N/A

Earnings	2023	Change
Revenue	$1.15B	N/A
Earnings	-$248.83M	N/A
EPS	-0.5975	N/A
Earnings Yield	-0.5288	N/A
Gross Margin	0.8689	N/A
Operating Margin	0.0575	N/A
Net income margin	-0.2155	N/A

Financial Strength	2023	Change
Total Assets	$2.47B	N/A
Total Debt	$1.19B	N/A
Cash on Hand	$78.00M	N/A
Debt to Equity	0.9644	23.65%
Cash to Debt	0.0653	42.86%
Current Ratio	0.5469	-5.68%